Curis Earns Buy Rating from HC Wainwright
CRIS Stock | USD 3.43 0.16 4.89% |
Slightly above 58% of all Curis' private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Curis Inc suggests that some traders are interested. Curis' investing sentiment can be driven by a variety of factors including economic data, Curis' earnings reports, geopolitical events, and overall market trends.
Curis |
HC Wainwright reissued their buy rating on shares of Curis in a research note released on Friday,Benzinga reports. They currently have a 20.00 price target on the biotechnology companys stock. Curis Trading Down 0.8 percent Curis stock traded down 0.03 during mid-day trading on Friday, reaching 3.95. The company had a
Read at thelincolnianonline.com
Curis Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Curis can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Curis Fundamental Analysis
We analyze Curis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Curis is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Curis Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Curis stock to make a market-neutral strategy. Peer analysis of Curis could also be used in its relative valuation, which is a method of valuing Curis by comparing valuation metrics with similar companies.
Peers
Curis Related Equities
MREO | Mereo BioPharma | 6.16 | ||||
XFOR | X4 Pharmaceuticals | 6.12 | ||||
ADAP | Adaptimmune Therapeutics | 1.75 | ||||
ARTL | Artelo Biosciences | 1.69 | ||||
INZY | Inozyme Pharma | 1.54 | ||||
DAWN | Day One | 1.05 | ||||
AFMD | Affimed NV | 0.91 | ||||
TERN | Terns Pharmaceuticals | 0.64 | ||||
CRVS | Corvus Pharmaceuticals | 2.57 | ||||
LPTX | Leap Therapeutics | 4.35 | ||||
APTO | Aptose Biosciences | 4.55 | ||||
PDSB | PDS Biotechnology | 10.12 |
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.